WERI-Rb-1 Cells








General information
Description | The WERI-Rb-1 cell line is derived from a retinoblastoma, a rare malignant tumor of the retina that typically manifests in early childhood. This cell line was established to provide a consistent and replicable model for the study of retinoblastoma biology, offering insights into the genetic, molecular, and cellular mechanisms underlying this form of cancer. WERI-Rb-1 cells are particularly valued in oncological research for their utility in investigating the pathophysiological processes and potential therapeutic targets for retinoblastoma. WERI-Rb-1 cells exhibit characteristics typical of retinoblastoma, including the expression of neuronal markers and the capability to form cell aggregates resembling Flexner-Wintersteiner rosettes, a hallmark of retinoblastoma histology. These cells have been used extensively to study the role of oncogenes and tumor suppressor genes in cancer development, with a focus on the RB1 gene, mutations of which are pivotal in the etiology of retinoblastoma. Furthermore, WERI-Rb-1 serves as an important tool in the evaluation of chemotherapeutic agents and novel drug delivery systems aimed at improving treatment outcomes for retinoblastoma patients. |
---|---|
Organism | Human |
Tissue | Eye |
Disease | Retinoblastoma |
Applications | 3D cell culture |
Synonyms | WERI-RB-1, WERI-Rb 1, WERI-Rb1, WERI-RB1, WERI Rb-1, WERIRb1, WERI, Wills Eye Research Institute-Retinoblastoma-1 |
Characteristics
Age | 1 year |
---|---|
Gender | Female |
Morphology | Round cells |
Growth properties | Suspension |
Identifiers / Biosafety / Citation
Citation | WERI-Rb-1 (Cytion catalog number 300632) |
---|---|
Biosafety level | 1 |
Expression / Mutation
Isoenzymes | ES-D, 1, G6PD, B, GLO-I, 2, Me-2, 1, PGM1, 1, PGM3, 0 |
---|---|
Tumorigenic | Yes, in rabbits |
Viruses | EBV -, HBV -, HCV -, HHV-8 -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
Reverse transcriptase | Negative |
Karyotype | human pseudodiploid karyotype with 3.9% polyploidy - 46(41-48)xx, +6, -10, -10, -14, -22, +3mar, add(3)(q25), add(3)(q25), add(4)(p15), add(5)(q35), i(6q), del(7)(p21), add(9)(q33), der(13)x2, add(16)(q23), add(16)(q23), i(17q), add(19)(q13) - apparently (uniparental?) disomic rearrangement of ch 13 - corresponds to reported karyotype |
Handling
Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
---|---|
Medium supplements | Supplement the medium with 10% FBS and 0.01 mg/mL insulin |
Subculturing | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 10^5 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
Freeze medium | As a cryopreservation medium, use 50% basal medium + 40% FBS + 10% DMSO, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|
Certificate of Analysis (CoA)
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
300632-120624 | Certificate of Analysis | 15. Apr. 2025 | 300632 |